Literature DB >> 17456056

Loss of bHLH transcription factor E2A activity in primary effusion lymphoma confers resistance to apoptosis.

Andreas Lietz1, Martin Janz, Mikael Sigvardsson, Franziska Jundt, Bernd Dörken, Stephan Mathas.   

Abstract

Similar to classical Hodgkin lymphoma (HL) tumour cells, primary effusion lymphoma (PEL) originates from mature B cells but displays a non-B cell phenotype, the mechanisms and consequences of which are not yet understood. This study showed that PEL lacked DNA binding activity of the B cell-determining transcription factors E2A, EBF and Pax5. PEL overexpressed the E2A antagonists ABF-1 and Id2, which have been described to block the B-cell differentiation program in classical HL. However, in contrast to HL cells, B lineage-inappropriate genes were not similarly upregulated in PEL, and reconstitution of B cell-specific E2A homodimer activity in PEL induced apoptosis. These data demonstrate that lineage infidelity in PEL is not as pronounced as in HL, and that the loss of the B cell-specific transcription factor E2A in PEL is implicated in apoptosis protection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17456056     DOI: 10.1111/j.1365-2141.2007.06583.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  5 in total

1.  Gene deregulation and spatial genome reorganization near breakpoints prior to formation of translocations in anaplastic large cell lymphoma.

Authors:  Stephan Mathas; Stephan Kreher; Karen J Meaburn; Korinna Jöhrens; Björn Lamprecht; Chalid Assaf; Wolfram Sterry; Marshall E Kadin; Masanori Daibata; Stefan Joos; Michael Hummel; Harald Stein; Martin Janz; Ioannis Anagnostopoulos; Evelin Schrock; Tom Misteli; Bernd Dörken
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-25       Impact factor: 11.205

Review 2.  Paradoxical role of Id proteins in regulating tumorigenic potential of lymphoid cells.

Authors:  Sumedha Roy; Yuan Zhuang
Journal:  Front Med       Date:  2018-07-24       Impact factor: 4.592

3.  Genomic loss of the putative tumor suppressor gene E2A in human lymphoma.

Authors:  Anne Steininger; Markus Möbs; Reinhard Ullmann; Karl Köchert; Stephan Kreher; Björn Lamprecht; Ioannis Anagnostopoulos; Michael Hummel; Julia Richter; Marc Beyer; Martin Janz; Claus-Detlev Klemke; Harald Stein; Bernd Dörken; Wolfram Sterry; Evelin Schrock; Stephan Mathas; Chalid Assaf
Journal:  J Exp Med       Date:  2011-07-25       Impact factor: 14.307

4.  E2A predicts prognosis of colorectal cancer patients and regulates cancer cell growth by targeting miR-320a.

Authors:  Ao Huang; Hongchao Zhao; Yingjun Quan; Runsen Jin; Bo Feng; Minhua Zheng
Journal:  PLoS One       Date:  2014-01-13       Impact factor: 3.240

Review 5.  The emerging role of Twist proteins in hematopoietic cells and hematological malignancies.

Authors:  N Merindol; A Riquet; V Szablewski; J-F Eliaou; A Puisieux; N Bonnefoy
Journal:  Blood Cancer J       Date:  2014-04-25       Impact factor: 11.037

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.